EDAP TMS S.A. (EDAP)

Market Cap	89.74M
Revenue (ttm)	74.01M
Net Income (ttm)	-24.68M
Shares Out	37.39M
EPS (ttm)	-0.66
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,413
Open	2.250
Previous Close	2.330
Day's Range	2.222 - 2.496
52-Week Range	1.210 - 3.240
Beta	-0.20
Analysts	Buy
Price Target	8.50 (+254.17%)
Earnings Date	Nov 6, 2025

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology-related and other indications. This segment also ...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Jul 31, 1997
• Employees: 310
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP
• Website: https://focalone.com

Financial Performance

In 2024, EDAP TMS's revenue was 64.12 million, an increase of 6.11% compared to the previous year's 60.42 million. Losses were -19.02 million, -10.20% less than in 2023.

Financial numbers in EUR

Analyst Summary

According to 3 analysts, the average rating for EDAP stock is "Buy." The 12-month stock price target is $8.5, which is an increase of 254.17% from the latest price.

Price Target

$8.5

(254.17% upside)

Analyst Consensus: Buy